griffin upgrades unilife

Unilife Corp Upgraded at Griffin Securities (UNIS)

September 16th, 2015 • 0 comments • Filed Under • by ABMN Staff

https://disallowed.com/assets/widget/stocktwits_share.png​

Unilife Corp (NASDAQ:UNIS) was upgraded by analysts at Griffin Securities from a “neutral” rating to a “buy” rating in a research note issued on Wednesday, The Fly reports. The brokerage presently has a $6.00 price objective on the stock. Griffin Securities’ price objective suggests a potential upside of 430.97% from the stock’s current price.
Several other brokerages have also recently issued reports on UNIS. Piper Jaffray reissued an “overweight” rating and set a $12.00 price objective (up previously from $10.00) on shares of Unilife Corp in a report on Thursday, July 30th. Jefferies Group lowered shares of Unilife Corp from a “buy” rating to a “hold” rating and lowered their target price for the stock from $8.00 to $1.50 in a research report on Thursday, August 6th. Finally, Zacks lowered shares of Unilife Corp from a “hold” rating to a “sell” rating in a research report on Monday, August 10th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Unilife Corp currently has an average rating of “Buy” and an average target price of $4.38.
Shares of Unilife Corp (NASDAQ:UNIS) traded up 3.5487% on Wednesday, hitting $1.1701. 775,749 shares of the stock were exchanged. The stock’s market cap is $142.11 million. The company’s 50 day moving average is $1.39 and its 200-day moving average is $2.59. Unilife Corp has a 52-week low of $1.12 and a 52-week high of $4.90.

​

Unilife Corp (NASDAQ:UNIS) last issued its quarterly earnings results on Monday, September 14th. The company reported ($0.16) earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.16). The business had revenue of $3.45 million for the quarter. Analysts predict that Unilife Corp will post ($0.46) EPS for the current fiscal year.
Unilife Corporation, is a drug delivery company. The Company has product platforms, including pre-filled syringes, drug reconstitution delivery systems, auto-injectors, wearable injectors, ocular delivery systems and other novel injectable drug delivery systems. The Company’s product platform includes: Pre-filled Syringes, Wearable Injectors, Auto-Injectors, Drug Reconstitution Delivery Systems, and Ocular Delivery Systems. Pre-filled Syringes, offers a single-chamber pre-filled syringe, Unifill. Wearable Injectors, offers pre-filled and disposable devices, ReadyToGo. Auto-Injectors, offers disposable and reusable auto-injectors, LISA and RITA. Drug Reconstitution Delivery Systems, offers dual-chamber pre-filled syringes, EZMix. Ocular Delivery Systems, offers localized and targeted delivery of ophthalmic therapies.